{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:04:20Z","timestamp":1794852260854,"version":"4.9.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T00:00:00Z","timestamp":1677110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T00:00:00Z","timestamp":1677110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>To describe the incidence and prevalence of pelvic inflammatory disease (PID) and to estimate the risk of cardiometabolic outcomes among women with PID compared to women without PID.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A UK retrospective matched cohort study using data from The Health Improvement Network. To assess cardiometabolic risk, women (aged\u2009\u2265\u200916\u00a0years) with PID were compared to matched controls without PID. Annual prevalence and incidence of PID (1998\u20132017) were estimated among women aged 16\u201350\u00a0years using annual cross-sectional and cohort analyses, respectively. Adjusted hazard ratios (aHR) and 95% CI for cardiometabolic outcomes were estimated using Cox proportional hazards models. The primary outcome was composite cardiovascular disease (CVD) and its subtypes, including ischaemic heart disease (IHD), heart failure (HF) and cerebrovascular disease. Secondary outcomes were hypertension, and type 2 diabetes mellitus (T2DM).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among the 715 recorded composite CVD events, the crude incidence rate per 1000 person-years was 1.5 among women with history of PID compared to 1.3 in matched controls. Compared to women without PID (N\u2009=\u200973,769), the aHRs for cardiometabolic outcomes among women with PID (N\u2009=\u200919,804) were: composite CVD 1.10 (95% CI 0.93\u20131.30); IHD 1.19 (95% CI 0.93\u20131.53); cerebrovascular disease 1.13 (95% CI 0.90\u20131.43); HF 0.92 (95% CI 0.62\u20131.35) hypertension 1.10 (95% CI 1.01\u20131.20); and T2DM 1.25 (95% CI 1.09\u20131.43). The prevalence (per 10,000 population) of PID was 396.5 in 1998 and 237 in 2017. The incidence (per 10,000 person-years) of PID was 32.4 in 1998 and 7.9 in 2017.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>There was no excess risk of composite CVD or its subtypes among women with history of PID compared to matched controls. Findings from our study suggest that history of PID was associated with an increased risk of hypertension and type 2 diabetes mellitus, two major risk factors for CVD. Additional studies are required to support these findings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12905-023-02214-5","type":"journal-article","created":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T04:03:58Z","timestamp":1677125038000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Risk of cardiometabolic outcomes among women with a history of pelvic inflammatory disease: a retrospective matched cohort study from the UK"],"prefix":"10.1186","volume":"23","author":[{"given":"Kelvin","family":"Okoth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Neil","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishnarajah","family":"Nirantharakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola J.","family":"Adderley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,23]]},"reference":[{"issue":"1","key":"2214_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/eurheartj\/ehz859","volume":"41","author":"A Timmis","year":"2020","unstructured":"Timmis A, Townsend N, Gale CP, Torbica A, Lettino M, Petersen SE, et al. European society of cardiology: cardiovascular disease statistics 2019. Eur Heart J. 2020;41(1):12\u201385.","journal-title":"Eur Heart J"},{"issue":"2","key":"2214_CR2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ijcard.2011.01.016","volume":"158","author":"M O\u2019Flaherty","year":"2012","unstructured":"O\u2019Flaherty M, Allender S, Taylor R, Stevenson C, Peeters A, Capewell S. The decline in coronary heart disease mortality is slowing in young adults (Australia 1976\u20132006): a time trend analysis. Int J Cardiol. 2012;158(2):193\u20138.","journal-title":"Int J Cardiol"},{"issue":"7","key":"2214_CR3","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1001\/jama.290.7.898","volume":"290","author":"UN Khot","year":"2003","unstructured":"Khot UN, Khot MB, Bajzer CT, Sapp SK, Ohman EM, Brener SJ, et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA. 2003;290(7):898.","journal-title":"JAMA"},{"key":"2214_CR4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3502","author":"K Okoth","year":"2020","unstructured":"Okoth K, Chandan JS, Marshall T, Thangaratinam S, Thomas GN, Nirantharakumar K, et al. Association between the reproductive health of young women and cardiovascular disease in later life: umbrella review. BMJ. 2020. https:\/\/doi.org\/10.1136\/bmj.m3502.","journal-title":"BMJ"},{"issue":"2","key":"2214_CR5","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.ijcard.2012.01.006","volume":"167","author":"TH Liou","year":"2013","unstructured":"Liou TH, Wu CW, Hao WR, Hsu MI, Liu JC, Lin HW. Risk of myocardial infarction in women with pelvic inflammatory disease. Int J Cardiol. 2013;167(2):416\u201320.","journal-title":"Int J Cardiol"},{"issue":"7","key":"2214_CR6","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1161\/STROKEAHA.110.612655","volume":"42","author":"PC Chen","year":"2011","unstructured":"Chen PC, Tseng TC, Hsieh JY, Lin HW. Association between stroke and patients with pelvic inflammatory disease: a nationwide population-based study in taiwan. Stroke. 2011;42(7):2074\u20136.","journal-title":"Stroke"},{"key":"2214_CR7","unstructured":"Ross J, Cole M, Evans C, Lyons D, Dean G, Cousins D, et al. United Kingdom National Guideline for the Management of Pelvic Inflammatory Disease [Internet]. British Association for Sexual Health and HIV; [cited 2023Feb22]. 2018. Available from: https:\/\/www.bashhguidelines.org\/media\/1170\/pid-2018.pdf."},{"key":"2214_CR8","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1161\/01.CIR.100.4.e20","volume":"100","author":"SE Epstein","year":"1999","unstructured":"Epstein SE, Zhou YF, Zhu J. Infection and atherosclerosis: emerging mechanistic paradigms. Circulation. 1999;100:e20.","journal-title":"Circulation"},{"key":"2214_CR9","doi-asserted-by":"crossref","unstructured":"Myland M, O\u2019Leary C, Bafadhal B, Dungarwalla M, Bhullar H, Pinder L, et al. IQVIA medical research data (IMRD). Springer International Publishing; 2021. pp. 67\u201376","DOI":"10.1007\/978-3-030-51455-6_4"},{"issue":"6","key":"2214_CR10","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1002\/pds.1919","volume":"19","author":"A Ruig\u00f3mez","year":"2010","unstructured":"Ruig\u00f3mez A, Mart\u00edn-Merino E, Garc\u00eda Rodr\u00edguez LA. Validation of ischemic cerebrovascular diagnoses in the health improvement network (THIN). Pharmacoepidemiol Drug Saf. 2010;19(6):579\u201385.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"2214_CR11","first-page":"251","volume":"19","author":"BT Blak","year":"2011","unstructured":"Blak BT, Thompson M, Dattani H, Bourke A. Generalisability of the health improvement network (THIN) database: demographics, chronic disease prevalence and mortality rates. Inform Prim Care. 2011;19(4):251\u20135.","journal-title":"Inform Prim Care"},{"issue":"7","key":"2214_CR12","doi-asserted-by":"publisher","first-page":"A253","DOI":"10.1016\/S1098-3015(10)74240-6","volume":"12","author":"B Blak","year":"2009","unstructured":"Blak B, Thompson M. Php88 how does the health improvement network (thin) data on prevalence of chronic diseases compare with national figures? Value Heal. 2009;12(7):A253.","journal-title":"Value Heal"},{"issue":"9","key":"2214_CR13","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1001\/jamaneurol.2019.1812","volume":"76","author":"NJ Adderley","year":"2019","unstructured":"Adderley NJ, Subramanian A, Nirantharakumar K, Yiangou A, Gokhale KM, Mollan SP, et al. Association between idiopathic intracranial hypertension and risk of cardiovascular diseases in women in the United Kingdom. JAMA Neurol. 2019;76(9):1088\u201398.","journal-title":"JAMA Neurol"},{"issue":"3","key":"2214_CR14","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1097\/OLQ.0b013e3181f22f3e","volume":"38","author":"CE French","year":"2011","unstructured":"French CE, Hughes G, Nicholson A, Yung M, Ross JD, Williams T, et al. Estimation of the rate of pelvic inflammatory disease diagnoses: trends in england, 2000\u20132008. Sex Transm Dis. 2011;38(3):158\u201362.","journal-title":"Sex Transm Dis"},{"key":"2214_CR15","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1001\/jama.2020.9151","volume":"325","author":"K Yadav","year":"2021","unstructured":"Yadav K, Lewis RJ. Immortal time bias in observational studies. JAMA J Am Med Assoc. 2021;325:686.","journal-title":"JAMA J Am Med Assoc"},{"issue":"8","key":"2214_CR16","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1002\/pds.1770","volume":"18","author":"S Dav\u00e9","year":"2009","unstructured":"Dav\u00e9 S, Petersen I. Creating medical and drug code lists to identify cases in primary care databases. Pharmacoepidemiol Drug Saf. 2009;18(8):704\u20137.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"11","key":"2214_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-019637","volume":"7","author":"J Watson","year":"2017","unstructured":"Watson J, Nicholson BD, Hamilton W, Price S. Identifying clinical features in primary care electronic health record studies: methods for codelist development. BMJ Open. 2017;7(11): e019637.","journal-title":"BMJ Open"},{"key":"2214_CR18","unstructured":"caliberresearch.org. CALIBER [Internet]. [cited 2020 Mar 14]. Available from: https:\/\/caliberresearch.org\/portal\/codelists"},{"key":"2214_CR19","unstructured":"clinicalcodes.org. ClinicalCodes Repository [Internet]. [cited 2021 Feb 26]. Available from: https:\/\/clinicalcodes.rss.mhs.man.ac.uk\/"},{"key":"2214_CR20","unstructured":"phpc.cam.ac.uk. Code Lists - Primary Care Unit [Internet]. [cited 2022 Oct 27]. Available from: https:\/\/www.phpc.cam.ac.uk\/pcu\/research\/research-groups\/crmh\/cprd_cam\/codelists\/"},{"issue":"10120","key":"2214_CR21","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(17)32520-5","volume":"391","author":"N Conrad","year":"2018","unstructured":"Conrad N, Judge A, Tran J, Mohseni H, Hedgecott D, Crespillo AP, et al. Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals. Lancet. 2018;391(10120):572\u201380.","journal-title":"Lancet"},{"issue":"1","key":"2214_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-012818","volume":"7","author":"M Schmidt","year":"2017","unstructured":"Schmidt M, Mansfield KE, Bhaskaran K, Nitsch D, S\u00f8rensen HT, Smeeth L, et al. Adherence to guidelines for creatinine and potassium monitoring and discontinuation following renin\u2013angiotensin system blockade: a UK general practice-based cohort study. BMJ Open. 2017;7(1): e012818.","journal-title":"BMJ Open"},{"issue":"7903","key":"2214_CR23","doi-asserted-by":"publisher","first-page":"f659","DOI":"10.1136\/bmj.f659","volume":"346","author":"S Gillam","year":"2013","unstructured":"Gillam S, Steel N. The quality and outcomes framework\u2014where next? BMJ. 2013;346(7903):f659.","journal-title":"BMJ"},{"issue":"10","key":"2214_CR24","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1111\/1471-0528.16692","volume":"128","author":"K Okoth","year":"2021","unstructured":"Okoth K, Wang J, Zemedikun D, Thomas GN, Nirantharakumar K, Adderley NJ. Risk of cardiovascular outcomes among women with endometriosis in the United Kingdom: a retrospective matched cohort study. BJOG. 2021;128(10):1598\u2013609.","journal-title":"BJOG"},{"issue":"23","key":"2214_CR25","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1001\/jama.2011.822","volume":"305","author":"ER Haut","year":"2011","unstructured":"Haut ER, Pronovost PJ. Surveillance bias in outcomes reporting. JAMA. 2011;305(23):2462\u20133.","journal-title":"JAMA"},{"issue":"4","key":"2214_CR26","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1155\/S1064744902000194","volume":"10","author":"H Gait\u00e1n","year":"2002","unstructured":"Gait\u00e1n H, Angel E, Diaz R, Parada A, Sanchez L, Vargas C. Accuracy of five different diagnostic techniques in mild-to-moderate pelvic inflammatory disease. Infect Dis Obstet Gynecol. 2002;10(4):171\u201380.","journal-title":"Infect Dis Obstet Gynecol"},{"issue":"6","key":"2214_CR27","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1136\/sti.2005.015701","volume":"81","author":"CR Cohen","year":"2005","unstructured":"Cohen CR, Mugo NR, Astete SG, Odondo R, Manhart LE, Kiehlbauch JA, et al. Detection of Mycoplasma genitalium in women with laparoscopically diagnosed acute salpingitis. Sex Transm Infect. 2005;81(6):463\u20136.","journal-title":"Sex Transm Infect"},{"key":"2214_CR28","first-page":"53","volume":"38","author":"R Morcos","year":"1993","unstructured":"Morcos R, Frost N, Hnat M, Petrunak A, Caldito G. Laparoscopic versus clinical diagnosis of acute pelvic inflammatory disease. J Reprod Med Obstet Gynecol. 1993;38:53\u20136.","journal-title":"J Reprod Med Obstet Gynecol"},{"issue":"2","key":"2214_CR29","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10654-020-00677-6","volume":"36","author":"KM Gokhale","year":"2021","unstructured":"Gokhale KM, Chandan JS, Toulis K, Gkoutos G, Tino P, Nirantharakumar K. Data extraction for epidemiological research (DExtER): a novel tool for automated clinical epidemiology studies. Eur J Epidemiol. 2021;36(2):165\u201378.","journal-title":"Eur J Epidemiol"},{"key":"2214_CR30","doi-asserted-by":"publisher","first-page":"611","DOI":"10.2147\/CLEP.S147175","volume":"9","author":"JL Lund","year":"2017","unstructured":"Lund JL, Horv\u00e1th-Puh\u00f3 E, Sz\u00e9pligeti SK, S\u00f8rensen HT, Pedersen L, Ehrenstein V, et al. Conditioning on future exposure to define study cohorts can induce bias: the case of low-dose acetylsalicylic acid and risk of major bleeding. Clin Epidemiol. 2017;9:611\u201326.","journal-title":"Clin Epidemiol"},{"issue":"7","key":"2214_CR31","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1258\/0956462991914447","volume":"10","author":"I Simms","year":"1999","unstructured":"Simms I, Rogers P, Charlett A. The rate of diagnosis and demography of pelvic inflammatory disease in general practice: England and Wales. Int J STD AIDS. 1999;10(7):448\u201351.","journal-title":"Int J STD AIDS"},{"key":"2214_CR32","unstructured":"Public Health England. Infection report HIV-STIs rates of pelvic inflammatory disease (PID) in England (2000\u20132013). 2015;9(22):2013\u20136."},{"key":"2214_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmj.g1538","volume":"348","author":"JDC Ross","year":"2014","unstructured":"Ross JDC, Hughes G. Why is the incidence of pelvic inflammatory disease falling? BMJ. 2014;348:1\u20132.","journal-title":"BMJ"},{"issue":"9907","key":"2214_CR34","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1016\/S0140-6736(13)62035-8","volume":"382","author":"CH Mercer","year":"2013","unstructured":"Mercer CH, Tanton C, Prah P, Erens B, Sonnenberg P, Clifton S, et al. Changes in sexual attitudes and lifestyles in Britain through the life course and over time: findings from the national surveys of sexual attitudes and lifestyles (Natsal). Lancet. 2013;382(9907):1781\u201394.","journal-title":"Lancet"},{"issue":"2","key":"2214_CR35","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1136\/sti.76.2.80","volume":"76","author":"I Simms","year":"2000","unstructured":"Simms I, Stephenson JM. Pelvic inflammatory disease epidemiology: what do we know and what do we need to know? Sex Transm Infect. 2000;76(2):80\u20137.","journal-title":"Sex Transm Infect"},{"issue":"5","key":"2214_CR36","first-page":"e2726","volume":"95","author":"CH Tseng","year":"2016","unstructured":"Tseng CH, Muo CH, Lin MC, Kao CH. Association between reduced risk of intracerebral hemorrhage and pelvic inflammatory disease. Med (United States). 2016;95(5):e2726.","journal-title":"Med (United States)."},{"issue":"3","key":"2214_CR37","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ijcard.2012.05.014","volume":"158","author":"KM Cheong","year":"2012","unstructured":"Cheong KM. Pelvic inflammatory disease and myocardial infarction. Int J Cardiol. 2012;158(3):463.","journal-title":"Int J Cardiol"},{"issue":"11","key":"2214_CR38","doi-asserted-by":"publisher","first-page":"6145","DOI":"10.1128\/IAI.67.11.6145-6151.1999","volume":"67","author":"Y Fan","year":"1999","unstructured":"Fan Y, Wang S, Yang X. Chlamydia trachomatis (mouse pneumonitis strain) induces cardiovascular pathology following respiratory tract infection. Infect Immun. 1999;67(11):6145\u201351.","journal-title":"Infect Immun"},{"issue":"4","key":"2214_CR39","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.cardfail.2008.01.002","volume":"14","author":"S Mavrogeni","year":"2008","unstructured":"Mavrogeni S, Manoussakis M, Spargias K, Kolovou G, Saroglou G, Cokkinos DV. Myocardial involvement in a patient with chlamydia trachomatis infection. J Card Fail. 2008;14(4):351\u20133.","journal-title":"J Card Fail"},{"key":"2214_CR40","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3389\/fimmu.2019.00087","volume":"10","author":"NCC Almeida","year":"2019","unstructured":"Almeida NCC, Queiroz MAF, Lima SS, Costa IB, Fossa MAA, Vallinoto ACR, et al. Association of chlamydia trachomatis, C. Pneumoniae, and IL-6 and IL-8 gene alterations with heart diseases. Front Immunol. 2019;10:87.","journal-title":"Front Immunol"},{"issue":"5406","key":"2214_CR41","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1126\/science.283.5406.1335","volume":"283","author":"K Bachmaier","year":"1999","unstructured":"Bachmaier K, Nikolaus N, De La Maza LM, Sukumar P, Hessel A, Penninger JM. Chlamydia infections and heart disease linked through antigenic mimicry. Science. 1999;283(5406):1335\u20139.","journal-title":"Science"},{"issue":"3","key":"2214_CR42","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1042\/CS20040174","volume":"108","author":"S Kofler","year":"2005","unstructured":"Kofler S, Nickel T, Weis M. Role of cytokines in cardiovascular diseases: a focus on endothelial responses to inflammation. Clin Sci (Lond). 2005;108(3):205\u201313.","journal-title":"Clin Sci (Lond)"},{"key":"2214_CR43","first-page":"1","volume":"2014","author":"CT Chan","year":"2014","unstructured":"Chan CT, Lieu M, Toh BH, Kyaw TS, Bobik A, Sobey CG, et al. Antibodies in the pathogenesis of hypertension. Biomed Res Int. 2014;2014:1\u20139.","journal-title":"Biomed Res Int"},{"issue":"7","key":"2214_CR44","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.2337\/db06-1491","volume":"56","author":"PD Cani","year":"2007","unstructured":"Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007;56(7):1761\u201372.","journal-title":"Diabetes"},{"issue":"9","key":"2214_CR45","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/S0735-1097(19)32362-9","volume":"73","author":"K Park","year":"2019","unstructured":"Park K, Egerman R, Sattari M, Kaufman N. Improving documentation of adverse pregnancy outcomes and assocaited cardiovascular risk in women. J Am Coll Cardiol. 2019;73(9):1756.","journal-title":"J Am Coll Cardiol"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-023-02214-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-023-02214-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-023-02214-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T04:05:24Z","timestamp":1677125124000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-023-02214-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,23]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2214"],"URL":"https:\/\/doi.org\/10.1186\/s12905-023-02214-5","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,23]]},"assertion":[{"value":"16 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Use of IQVIA Medical Research Data (IMRD-UK) is approved by the UK Research Ethics Committee (reference number: 18\/LO\/0441); in accordance with this approval, the study protocol was reviewed and approved by an independent Scientific Review Committee (SRC) (Reference number: 19THIN083). THIN is a registered trademark of Cegedim SA in the United Kingdom and other countries. Reference made to the THIN database is intended to be descriptive of the data asset licensed by IQVIA. This work uses de-identified data provided by patients as a part of their routine primary care. All methods were carried out in accordance with the relevant guidelines and regulations. Given that this is a retrospective study using de-identified electronic health records formal informed consent was waived by the UK Health Research Authority.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No patient was involved in the design and conduct of the study. The study used anonymised electronic health records. The results were not disseminated to the study participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"80"}}